Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Fukuda Denshi Co's Other Stockholders Equity for the quarter that ended in Mar. 2026 was 円11,789 Mil.
Fukuda Denshi Co's quarterly Other Stockholders Equity
increased
from Sep. 2025 (円8,104 Mil) to Dec. 2025 (円9,652 Mil) and
increased
from Dec. 2025 (円9,652 Mil) to Mar. 2026 (円11,789 Mil).
Fukuda Denshi Co's annual Other Stockholders Equity
declined
from Mar. 2024 (円6,785 Mil) to Mar. 2025 (円6,342 Mil) but then
increased
from Mar. 2025 (円6,342 Mil) to Mar. 2026 (円11,789 Mil).
Fukuda Denshi Co Other Stockholders Equity Related Terms
Fukuda Denshi Co Other Stockholders Equity Historical Data
* Premium members only.
The historical data trend for Fukuda Denshi Co's Other Stockholders Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Other Stockholders Equity of 円11,789 Mil mean?
Fukuda Denshi Co (TSE:6960) has a Other Stockholders Equity of 円11,789 Mil as of Mar. 2026. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Fukuda Denshi Co and its competitors.
Is Fukuda Denshi Co's Other Stockholders Equity too high?
Fukuda Denshi Co's current Other Stockholders Equity is 円11,789 Mil. Overall, Fukuda Denshi Co has a GF Score™ of 84/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Fukuda Denshi Co's Other Stockholders Equity compare to ABT and SYK?
Fukuda Denshi Co's Other Stockholders Equity of 円11,789 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Medical Devices & Instruments company?
A good Other Stockholders Equity depends on the Medical Devices & Instruments industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Fukuda Denshi Co and its competitors. Fukuda Denshi Co's current Other Stockholders Equity is 円11,789 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fukuda Denshi Co stock overvalued right now?
Based on GuruFocus' analysis, Fukuda Denshi Co (TSE:6960) is currently considered Significantly Overvalued. The stock's GF Value™ is 円7,338.65, compared to a current price of 円11,570.00 — trading 57.7% above its estimated fair value. The current Other Stockholders Equity is 円11,789 Mil. Fukuda Denshi Co's overall GF Score™ is 84/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Fukuda Denshi Co (TSE:6960), the current Other Stockholders Equity is 円11,789 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fukuda Denshi Co (TSE:6960) Overvalued in 2026?
Based on GuruFocus' analysis, Fukuda Denshi Co stock appears to be overvalued.
The current stock price of 円11,570.00 is trading 57.7% above its estimated GF Value™ of 円7,338.65.
GuruFocus considers Fukuda Denshi Co to be Significantly Overvalued.
Key valuation signals for TSE:6960:
Other Stockholders Equity: 円11,789 Mil
GF Value™: 円7,338.65 vs. price of 円11,570.00 (57.7% above fair value)
No single metric tells the full story. See the TSE:6960 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Fukuda Denshi Co Ltd develops and manufactures medical electronic equipment. The firm operates in four segments: physiological diagnostic equipment, patient monitoring equipment, medical treatment equipment, and consumables and other products. The physiological diagnostic equipment business sells electrocardiographs, vascular screening systems, and blood cell counters. The patient monitoring equipment segment sells patient monitors and transmitters. The medical treatment equipment segment contributes the largest proportion of revenue and sells pacemakers and medical equipment for home treatment. The consumables and other products segment sells disposable electrodes and consumables used for the firm's devices. Fukuda Denshi generates the vast majority of its sales in Japan.
84GF Score
Get the complete analysis for TSE:6960
Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:6960 has been successfully added to your 
